Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M234Revenue (TTM) $M31.7Net Margin (%)-159.8Altman Z-Score-9.2
Enterprise Value $M130EPS (TTM) $-0.6Operating Margin %-160.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-0.2Pre-tax Margin (%)-159.8Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %--Quick Ratio3.8Cash flow > EarningsN
Price/Sales7.15-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M92.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RIGLJohn Paulson 2016-03-31 Add0.01%$1.94 - $3.03
($2.48)
$ 2.542%Add 89.09%999,700
RIGLCharles Brandes 2016-03-31 Sold Out $1.94 - $3.03
($2.48)
$ 2.542%Sold Out0
RIGLJohn Paulson 2015-12-31 Buy 0.01%$2.53 - $3.55
($3.05)
$ 2.54-17%New holding528,700
RIGLCharles Brandes 2015-09-30 Reduce$2.36 - $3.35
($2.98)
$ 2.54-15%Reduce -44.07%25,000
RIGLCharles Brandes 2015-03-31 Buy $2.06 - $3.68
($2.74)
$ 2.54-7%New holding44,700
RIGLCharles Brandes 2014-09-30 Sold Out $1.97 - $3.84
($2.81)
$ 2.54-10%Sold Out0
RIGLCharles Brandes 2014-03-31 Buy $2.7 - $4.75
($3.53)
$ 2.54-28%New holding15,000
RIGLGeorge Soros 2011-12-31 Sold Out -0.0019%$6.68 - $8.3
($7.59)
$ 2.54-67%Sold Out0
RIGLFirst Eagle Investment 2011-06-30 Sold Out $7.11 - $9.19
($8.07)
$ 2.54-69%Sold Out0
RIGLGeorge Soros 2011-06-30 Buy $7.18 - $9.19
($8.08)
$ 2.54-69%New holding14,500
RIGLFirst Eagle Investment 2011-03-31 Buy $6.54 - $7.74
($7.06)
$ 2.54-64%New holding46,700
RIGLGeorge Soros 2010-09-30 Sold Out $6.94 - $8.8
($8.11)
$ 2.54-69%Sold Out0
RIGLGeorge Soros 2010-03-31 Add$7.41 - $9.83
($8.55)
$ 2.54-70%Add 34.29%14,100
RIGLGeorge Soros 2009-12-31 Buy $6.08 - $9.86
($7.86)
$ 2.54-68%New holding10,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RIGL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-06-10Sell41,666$3.68-30.98view
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-04-01Sell10,000$3.75-32.27view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2214.41view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2214.41view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.56-0.78view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-31.54view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.64-3.79view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-26.8view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2012-09-13Sell4,151$10.43-75.65view
Maynard Ryan DEVP & CFO 2012-09-12Sell23,302$10.67-76.19view

Quarterly/Annual Reports about RIGL:

News about RIGL:

Articles On GuruFocus.com
Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 

More From Other Websites
ETF’s with exposure to Rigel Pharmaceuticals, Inc. : May 19, 2016 May 19 2016
Rigel Pharmaceuticals, Inc. :RIGL-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 12 2016
RIGEL PHARMACEUTICALS INC Financials May 10 2016
Rigel to Present at Upcoming American Association of Immunologists (AAI) Annual Meeting May 05 2016
Rigel to Present at Upcoming American Association of Immunologists (AAI) Annual Meeting May 05 2016
Edited Transcript of RIGL earnings conference call or presentation 3-May-16 9:00pm GMT May 04 2016
RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 03 2016
Rigel Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today May 03 2016
Rigel Announces First Quarter 2016 Financial Results May 03 2016
RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 03 2016
Rigel Announces First Quarter 2016 Financial Results May 03 2016
Q1 2016 Rigel Pharmaceuticals Inc Earnings Release - After Market Close May 03 2016
Rigel Announces Conference Call and Webcast to Report First Quarter 2016 Financial Results Apr 26 2016
Rigel Announces Conference Call and Webcast to Report First Quarter 2016 Financial Results Apr 26 2016
Rigel Pharma upgraded by JP Morgan Apr 22 2016
Rigel Announces Presentations at Upcoming American Association of Cancer Research (AACR) Conference Apr 12 2016
Rigel Announces Presentations at Upcoming American Association of Cancer Research (AACR) Conference Apr 12 2016
Rigel Completes Enrollment of FIT Phase 3 Program for Fostamatinib in ITP Apr 01 2016
Rigel Completes Enrollment of FIT Phase 3 Program for Fostamatinib in ITP Apr 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)